Fluoxetine is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. It is used for the treatment of major depressive disorder, obsessive–compulsive disorder (OCD), bulimia nervosa, panic disorder and premenstrual dysphoric disorder. It may decrease the risk of suicide in those over the age of 65.

The global Fluoxetine market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Fluoxetine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Fluoxetine market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Fluoxetine in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Fluoxetine manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Teva
Sun Pharmaceutical
Sandoz
Mylan
Wockhardt
Dr.Reddy's Laboratories
Pharmaceutical Associates Inc.
Lannett Company
Aurobindo Pharma
Alembic Pharmaceuticals
Alvogen
Torrent Pharmaceuticals
Suzhou YUSHI Pharmaceutical
Changzhou Siyao Pharmaceutical

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Tablets
Capsules
Oral Solution

Segment by Application
Depression
Obsessive–compulsive disorder
Panic disorder
Bulimia nervosa
Others